{"id":"https://openalex.org/W187459702","doi":"https://doi.org/10.1182/blood.v122.21.5356.5356","title":"Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia","display_name":"Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W187459702","doi":"https://doi.org/10.1182/blood.v122.21.5356.5356","mag":"187459702"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.5356.5356","doi":"https://doi.org/10.1182/blood.v122.21.5356.5356","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.5356.5356","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023015733","display_name":"Rupin Shah","orcid":"https://orcid.org/0009-0009-5197-6904","observed_orcids":["https://orcid.org/0009-0009-5197-6904"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rupin A Shah","raw_affiliation_strings":["Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036927134","display_name":"Satyajit Mohite","orcid":"https://orcid.org/0000-0002-2873-3025","observed_orcids":["https://orcid.org/0000-0002-2873-3025"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Satyajit Mohite","raw_affiliation_strings":["Department of Lymphoma/Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024470416","display_name":"Veerabhadran Baladandayuthapani","orcid":"https://orcid.org/0000-0001-9107-3157","observed_orcids":["https://orcid.org/0000-0001-9107-3157"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Veerabhadran Baladandayuthapani","raw_affiliation_strings":["Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Biostatistics, The University of Texas MD, Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Biostatistics, The University of Texas MD, Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008785159","display_name":"Sheeba K. Thomas","orcid":"https://orcid.org/0000-0001-8596-7058","observed_orcids":["https://orcid.org/0000-0001-8596-7058","https://orcid.org/0000-0001-9806-8529"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheeba K. Thomas","raw_affiliation_strings":["Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113916086","display_name":"Donna M. Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna M. Weber","raw_affiliation_strings":["Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wang","raw_affiliation_strings":["Department of Lymphoma & Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA,","Department of Lymphoma and Myeloma; The University of Texas M. D. Anderson Cancer Center; Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma & Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Lymphoma and Myeloma; The University of Texas M. D. Anderson Cancer Center; Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007796652","display_name":"Raymond Alexanian","orcid":"https://orcid.org/0000-0002-3030-7404","observed_orcids":["https://orcid.org/0000-0002-3030-7404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond Alexanian","raw_affiliation_strings":["Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015342719","display_name":"Muzaffar H. Qazilbash","orcid":"https://orcid.org/0000-0003-2876-2886","observed_orcids":["https://orcid.org/0000-0003-2876-2886"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Muzaffar H Qazilbash","raw_affiliation_strings":["Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA,","Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066894053","display_name":"Uday Popat","orcid":"https://orcid.org/0000-0002-7592-2224","observed_orcids":["https://orcid.org/0000-0002-7592-2224"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uday R Popat","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048913229","display_name":"Richard E. Champlin","orcid":"https://orcid.org/0000-0002-4314-5037","observed_orcids":["https://orcid.org/0000-0002-4314-5037"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E Champlin","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053904944","display_name":"Nina D. Shah","orcid":"https://orcid.org/0000-0002-1971-8173","observed_orcids":["https://orcid.org/0000-0002-1971-8173"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina Shah","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068834306","display_name":"Qaiser Bashir","orcid":"https://orcid.org/0000-0002-4086-6453","observed_orcids":["https://orcid.org/0000-0002-4086-6453"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qaiser Bashir","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026422612","display_name":"Simrit Parmar","orcid":"https://orcid.org/0000-0003-1798-9233","observed_orcids":["https://orcid.org/0000-0003-1798-9233"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simrit Parmar","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029237145","display_name":"Yago L. Nieto","orcid":"https://orcid.org/0000-0001-6034-8939","observed_orcids":["https://orcid.org/0000-0001-6034-8939"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yago Nieto","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039574726","display_name":"Sairah Ahmed","orcid":"https://orcid.org/0000-0001-7302-8299","observed_orcids":["https://orcid.org/0000-0001-7302-8299"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sairah Ahmed","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038235561","display_name":"Robert Zygmunt Orlowski","orcid":"https://orcid.org/0000-0002-5723-4129","observed_orcids":["https://orcid.org/0000-0002-5723-4129"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Z. Orlowski","raw_affiliation_strings":["Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108104588","display_name":"Jatin J. Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jatin J. Shah","raw_affiliation_strings":["Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015342719","https://openalex.org/A5024470416"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2135,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.58221614,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"122","issue":"21","first_page":"5356","last_page":"5356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasma-cell-leukemia","display_name":"plasma cell leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/circulating-plasma-cells","display_name":"circulating plasma cells","score":0.9940000176429749},{"id":"https://openalex.org/keywords/complete-blood-count","display_name":"complete blood count","score":0.8659999966621399},{"id":"https://openalex.org/keywords/who-criteria","display_name":"WHO criteria","score":0.6359999775886536},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6899999976158142},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8539999723434448},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6359999775886536},{"id":"https://openalex.org/keywords/hyper-cvad","display_name":"hyper-CVAD","score":0.7490000128746033},{"id":"https://openalex.org/keywords/primary-plasma-cell-leukemia","display_name":"primary plasma cell leukemia","score":0.7409999966621399},{"id":"https://openalex.org/keywords/secondary-plasma-cell-leukemia","display_name":"secondary plasma cell leukemia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/plasma-cell-dyscrasia","display_name":"plasma cell dyscrasia","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cutoff-values","display_name":"cut-off values","score":0.39899998903274536},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.4580000042915344},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.3409999907016754},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2780353925","wikidata":"https://www.wikidata.org/wiki/Q7201765","display_name":"Plasma cell leukemia","level":3,"score":0.8278027772903442},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.703653872013092},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6199888586997986},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5637990236282349},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.5618616938591003},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5427224636077881},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5196889042854309},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.505486249923706},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.46628332138061523},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3741980195045471},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.36202311515808105},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3479786217212677},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3450459837913513}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.5356.5356","doi":"https://doi.org/10.1182/blood.v122.21.5356.5356","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.5356.5356","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6499999761581421,"display_name":"No poverty","id":"https://metadata.un.org/sdg/1"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2358854363","https://openalex.org/W2399446920","https://openalex.org/W4290257576","https://openalex.org/W2599118468","https://openalex.org/W1995195719","https://openalex.org/W2955024808","https://openalex.org/W4231960749","https://openalex.org/W1942971125","https://openalex.org/W2411306717","https://openalex.org/W2063832998"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Plasma":[2],"cell":[3,9,39,395,453,624,651],"leukemia":[4],"(PCL)":[5],"is":[6,77,728],"a":[7,14,82,222,270,293,342,507,530,549,571,595,614,627,656,729,734,739,752,778],"plasma":[8,28,38,71,158,177,216,234,255,350,417,452,457,623,650,680,700,704,723],"dyscrasia":[10],"that":[11,109,120,261,440,759],"predicts":[12],"for":[13,45,147,274,283,447,488],"shortened":[15],"survival.":[16],"World":[17],"Health":[18],"Organization":[19],"(WHO)":[20],"criteria":[21,44,113,402,415,446,464,527,546,592,611,767],"require":[22],"the":[23,32,67,74,89,111,165,183,200,213,219,226,237,243,252,258,265,280,288,331,400,436,444,463,466,481,503,525,544,567,590,609,663,707,713,719,726,765],"presence":[24,68,307,448,720],"of":[25,69,92,114,140,164,185,203,215,308,333,345,352,403,449,462,468,480,502,510,524,533,543,552,566,574,589,598,608,617,649,675,677,698,709,717,721,768,785],"\u226520%":[26],"circulating":[27,156],"cells":[29,72,162,178,217,235,256,351,418,681,701,705,724],"(CPC)":[30],"in":[31,53,73,182,218,225,276,361,368,374,380,642,682,725,751,777],"peripheral":[33,75,684],"blood,":[34,685],"and":[35,51,105,128,168,246,287,296,323,347,377,391,422,455,519,584,653,738],"an":[36],"absolute":[37,169,349,451,703],"count":[40,103,454],"\u22652,000/\u00b5l":[41],"(microliter).":[42],"These":[43],"PCL":[46,312,321,328,404,769],"were":[47,172,179,240,290,299,304,419,486],"established":[48],"by":[49,359,495,559],"Noel":[50],"Kyle":[52],"1974,":[54],"but":[55,430,475],"subsequent":[56],"studies":[57],"to":[58,80,87,208,230,251,635,748,770,787],"further":[59],"validate":[60],"this":[61],"cut":[62,238,259,285],"off":[63,239,260],"are":[64],"lacking.":[65],"Since":[66],"any":[70,96,209,309,690,722,772],"blood":[76,102],"now":[78],"known":[79],"be":[81,749],"poor-risk":[83],"feature,":[84],"we":[85,686,756],"sought":[86],"compare":[88],"overall":[90,643],"survival":[91,195,248,277,644],"patients":[93,537,602],"(pts)":[94],"with":[95,107,155,233,254,292,306,337,385,492,556,630,655,660,733,774],"CPC":[97,204,310,344,426,474,496,518,560,583,775],"observed":[98,776],"on":[99,315,621,646,695],"routine":[100,779],"complete":[101],"(CBC)":[104],"differential":[106],"those":[108],"meet":[110,443,478,522,587],"WHO":[112,316,401,433,445,482,504,526,545,568,591,610],"PCL.":[115],"Methods":[116],"We":[117,152,211,268],"evaluated":[118],"pts":[119,154,253,303,325,340,355,376,384,398,439,472,514,579,678],"received":[121,387],"hyper-CVAD":[122],"(cyclophosphamide":[123],"/vincristine/doxorubicin/dex);":[124],"CBAD":[125],"(cyclophosphamide/bortezomib/doxorubicin/":[126],"dex),":[127],"DT-PACE":[129],"(dexamethasone/thalidomide/":[130],"cisplatin":[131],"/etoposide":[132],"/":[133],"doxorubicin/":[134],"cyclophosphamide)":[135],"chemotherapy":[136],"at":[137,405,499,563,706],"The":[138],"University":[139],"Texas":[141],"M.":[142],"D.":[143],"Anderson":[144],"Cancer":[145],"Center":[146],"multiple":[148],"myeloma":[149],"from":[150,199,228,633],"2003-2012.":[151],"included":[153],"blasts,":[157],"cells,":[159,458],"or":[160,176,190,311,497,541,561,606,702],"plasmacytoid":[161],"regardless":[163],"percentage":[166],"(%)":[167],"count.":[170],"Pts":[171,232,491,555],"excluded":[173],"if":[174],"blasts":[175],"seen":[180],"transiently":[181],"setting":[184],"leukopheresis,":[186],"growth":[187],"factor":[188,629],"support,":[189],"during":[191,408,465],"severe":[192],"sepsis.":[193],"Overall":[194],"(OS)":[196],"was":[197,249,262,638,666],"defined":[198,241,263],"first":[201,420],"detection":[202],"until":[205],"death":[206],"due":[207],"cause.":[210],"treated":[212],"%":[214,456,625,699],"CBC":[220,727],"as":[221,242,264,626],"continuous":[223],"variable":[224],"range":[227],"1%":[229,634],"20%.":[231],"below":[236],"\u201clow\u201d":[244],"group":[245],"their":[247,409,469,683,696],"compared":[250],"above":[257],"\u201chigh\u201d":[266],"group.":[267],"conducted":[269],"log":[271],"rank":[272],"test":[273],"difference":[275,641,693],"curves":[278],"between":[279],"two":[281],"groups":[282],"each":[284],"off,":[286],"results":[289,298],"verified":[291,654],"Cox":[294,657],"model":[295],"both":[297,450,542,607],"identical.":[300],"Results":[301],"85":[302],"identified":[305],"diagnosed":[313],"based":[314,389,645,694],"criteria;":[317],"19":[318,534],"had":[319,326,341,356,425,473,506,517,529,548,570,582,594,613],"primary":[320],"(pPCL)":[322],"66":[324],"secondary":[327],"(sPCL).":[329],"At":[330],"time":[332,708],"diagnosis,":[334],"83":[335],"(2":[336],"unknown":[338],"values)":[339],"median":[343,348,508,531,550,572,596,615],"4%":[346],"178/\u00b5L.":[353],"73":[354],"cytogenetic":[357],"abnormalities":[358],"florescence":[360],"situ":[362],"hybridization":[363],"studies,":[364],"including":[365,411],"deletion/monosomy":[366],"13":[367,459],"32":[369],"pts,":[370],"IgH":[371],"gene":[372],"rearrangement":[373],"24":[375],"TP53":[378],"deletions":[379],"12":[381],"pts.":[382,490],"17/19":[383],"pPCL":[386,493,513,536],"bortezomib":[388],"therapy":[390],"14/19":[392],"underwent":[393],"stem":[394],"transplant.":[396],"26":[397],"met":[399,414,432,460,498,539,562,604],"some":[406],"point":[407],"disease,":[410],"11":[412],"who":[413,424,515,538,580,603],"when":[416],"detected,":[421],"15":[423],"<":[427],"20%":[428],"initially,":[429],"subsequently":[431],"criteria.":[434,483],"Of":[435],"remaining":[437],"57":[438],"did":[441,476,520,585,687],"not":[442,477,521,586,688],"one":[461,501,565],"course":[467],"disease.":[470],"44":[471],"either":[479,523,540,588,605],"Survival":[484],"data":[485,762],"available":[487],"79/85":[489],"(either":[494,558],"least":[500,564],"criteria)":[505,569],"OS":[509,532,551,573,597,616,676],"18.5":[511],"months.":[512,554,619],"only":[516,581],"(n=5)":[528],"months;":[535,600],"(n=13)":[547],"18":[553],"sPCL":[557,578,601],"5":[575,599],"months":[576],"(n=61).":[577],"(n=39)":[593],"(n=22)":[612],"4":[618],"Based":[620],"evaluating":[622],"dichotomous":[628],"cut-off":[631],"ranging":[632],"20%,":[636],"there":[637],"no":[639],"significant":[640,692],"specific":[647],"levels":[648],"percent,":[652],"model,":[658],"however":[659],"many":[661],"cut-offs,":[662],"sample":[664],"size":[665],"small":[667],"potentially":[668],"limiting":[669],"analysis.":[670],"Conclusion":[671],"In":[672],"our":[673],"analysis":[674],"having":[679],"find":[689],"statistically":[691],"degree":[697],"diagnosis.":[710],"This":[711],"supports":[712],"hypothesis":[714],"that,":[715],"irrespective":[716],"quantity,":[718],"poor":[730,741],"prognostic":[731],"indicator,":[732],"similar":[735],"natural":[736],"history":[737],"uniformly":[740],"OS.":[742],"While":[743],"these":[744,760],"findings":[745],"will":[746],"need":[747],"validated":[750],"larger,":[753],"independent":[754],"dataset,":[755],"would":[757],"propose":[758],"initial":[761],"support":[763],"redefining":[764],"diagnostic":[766],"include":[771],"pt":[773],"CBC.":[780],"Disclosures:":[781],"No":[782],"relevant":[783],"conflicts":[784],"interest":[786],"declare.":[788]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}
